Anika Therapeutics ANIK Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$3.31M+16.6% | -$5.06M-3.8% | $0+100% | -$2.33M+92.2% | -$3.97M-4,411% | ||
| $1.51M+17.6% | $1.41M+1.7% | $1.32M-15.5% | $1.39M-25.2% | $1.28M-26.0% | ||
| $1.83M-28.1% | $6.64M+132% | $2.46M+9.0% | $2.22M-34.7% | $2.55M-34.5% | ||
| -$684K-262% | -$4.85M-3,628% | $4.64M+193% | $6.87M+37.0% | -$189K+82.3% | ||
| $1.45M-1.2% | $1.43M-49.3% | $648K-50.4% | $1.89M+55.2% | $1.47M-56.9% | ||
| -$1.28M— | -$1.24M-174% | —— | -$1.73M+4.6% | —— | ||
| $853K— | $8.69M+119% | $5.51M-1.1% | —— | —— | ||
| -$701K— | -$10.35M-90.3% | -$5.28M+1.4% | -$13K+99.7% | $0+100% | ||
| -$2.61M-1,178% | -$16.46M-335% | —— | $4.82M+1,162% | -$204K+96.5% | ||
| -$2.13M-28.8% | -$6.28M-112% | $3.99M— | $4.98M— | -$1.66M+63.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Anika Therapeutics generate?
- Anika Therapeutics (ANIK) generated $6.0M in operating cash flow over the trailing twelve months.
- What is Anika Therapeutics's free cash flow?
- After $5.4M of capital expenditures, Anika Therapeutics's free cash flow was $562.0K over the trailing twelve months, up 105.1% year over year.
- Where does Anika Therapeutics's cash flow data come from?
- Every line is extracted from Anika Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
